Deflazacort - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for deflazacort and what is the scope of patent protection?
Deflazacort
is the generic ingredient in one branded drug marketed by Ptc Therap and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for deflazacort.
Summary for deflazacort
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
Drug Master File Entries: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 23 |
Patent Applications: | 7,529 |
What excipients (inactive ingredients) are in deflazacort? | deflazacort excipients list |
DailyMed Link: | deflazacort at DailyMed |
Recent Clinical Trials for deflazacort
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Parc de Salut Mar | Phase 1 |
FibroGen | Phase 3 |
Catabasis Pharmaceuticals | Phase 1 |